Understanding how a virus manipulates the immune system during chronic infection.

Gammaherpesvirus protein kinase: a master manipulator of the host during chronic infection.

['FUNDING_R01'] · MEDICAL COLLEGE OF WISCONSIN · NIH-11120865

This study is looking at how a common virus that many adults have can affect the immune system and lead to certain types of blood cancers, with the hope of finding new ways to treat or prevent these conditions.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorMEDICAL COLLEGE OF WISCONSIN (nih funded)
Locations1 site (MILWAUKEE, UNITED STATES)
Trial IDNIH-11120865 on ClinicalTrials.gov

What this research studies

This research investigates how gammaherpesviruses, which infect over 95% of adults globally, influence the immune system and contribute to B cell lymphomas. The study focuses on a specific viral protein kinase that plays a crucial role in the virus's ability to persist in the host and evade immune responses. By examining the interactions between this viral protein and immune cells, particularly macrophages and B cells, the research aims to uncover mechanisms that could lead to new treatments or preventive strategies for virus-related lymphomas.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals who are at risk for or have been diagnosed with B cell lymphomas associated with gammaherpesvirus infections.

Not a fit: Patients who do not have gammaherpesvirus infections or related B cell lymphomas may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to novel therapeutic targets for preventing gammaherpesvirus-driven lymphomas.

How similar studies have performed: Previous research has shown that targeting viral mechanisms can lead to breakthroughs in understanding chronic infections and their associated cancers, suggesting potential success for this approach.

Where this research is happening

MILWAUKEE, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.